DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
Display Options:
Drug type
Therapeutic Area
Route of administration
Mechanism of Action
Indication
Status
Total:
10647
MK-2748
1
Small molecule
Investigational
Unknown
Unknown
Hepatitis C
Unknown
MK-2748
×
Maximum Phase:
1
First Approval:
None
UNII:
7YM030A71C
Molecule Type:
Small molecule
Molecular Formula:
C42H56N6O10S
Molecular Weight:
837.01
AlogP:
3.84
PSA:
204.33
HBD:
3.0
HBA:
#RotB:
8.0
Source:
RUNIMOTAMAB
1
Antibody
Investigational
Unknown
Unknown
Neoplasms
Unknown
RUNIMOTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
F8Z9VSZ0K1
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CYC065
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
CYC065
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
E-7820
1
Small molecule
Investigational
Unknown
Unknown
Colonic Neoplasms; Colorectal Neoplasms; Neoplasms; Rectal Neoplasms
Unknown
E-7820
×
Maximum Phase:
1
First Approval:
None
UNII:
TVH5K7949N
Molecule Type:
Small molecule
Molecular Formula:
C17H12N4O2S
Molecular Weight:
336.38
AlogP:
3.02
PSA:
109.54
HBD:
2.0
HBA:
#RotB:
3.0
Source:
ASP-8374
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
T-cell immunoreceptor with Ig and ITIM domains antagonist
ASP-8374
×
Maximum Phase:
1
First Approval:
None
UNII:
TB50XV90MW
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CP-459632
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Fibroblast growth factor receptor inhibitor
CP-459632
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
AMG-427
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
AMG-427
×
Maximum Phase:
1
First Approval:
None
UNII:
P9I9Z3MF7Z
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PF-06815345
1
Small molecule
Investigational
Unknown
Unknown
Hypercholesterolemia
Unknown
PF-06815345
×
Maximum Phase:
1
First Approval:
None
UNII:
4H9X9HO87K
Molecule Type:
Small molecule
Molecular Formula:
C27H29ClFN9O4
Molecular Weight:
598.04
AlogP:
4.02
PSA:
142.18
HBD:
1.0
HBA:
#RotB:
8.0
Source:
REGN-3048
1
Unknown
Investigational
Unknown
Unknown
Severe Acute Respiratory Syndrome
Unknown
REGN-3048
×
Maximum Phase:
1
First Approval:
None
UNII:
8HPY7RGH6D
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
IGM-2323
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
IGM-2323
×
Maximum Phase:
1
First Approval:
None
UNII:
F3HG38I0T1
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIP-1095 I-131
1
Unknown
Investigational
Unknown
Unknown
Prostatic Neoplasms, Castration-Resistant
Unknown
MIP-1095 I-131
×
Maximum Phase:
1
First Approval:
None
UNII:
7DM27RQ9V0
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LITOXETINE
1
Small molecule
Investigational
Unknown
Unknown
Urinary Incontinence
Unknown
LITOXETINE
×
Maximum Phase:
1
First Approval:
None
UNII:
9980ST005G
Molecule Type:
Small molecule
Molecular Formula:
C16H19NO
Molecular Weight:
241.33
AlogP:
3.11
PSA:
21.26
HBD:
1.0
HBA:
#RotB:
3.0
Source:
PF-04995274
1
Small molecule
Investigational
Unknown
Unknown
Depressive Disorder, Major; Depressive Disorder, Treatment-Resistant
Unknown
PF-04995274
×
Maximum Phase:
1
First Approval:
None
UNII:
XI179PG9LV
Molecule Type:
Small molecule
Molecular Formula:
C23H32N2O6
Molecular Weight:
432.52
AlogP:
2.63
PSA:
86.42
HBD:
1.0
HBA:
#RotB:
7.0
Source:
BOTENSILIMAB
1
Antibody
Investigational
Unknown
Unknown
Carcinoma, Non-Small-Cell Lung; Endometrial Neoplasms; Hemangiosarcoma; Neoplasms; Ovarian Neoplasms; Carcinoma, Renal Cell; Colorectal Neoplasms; Melanoma
Unknown
BOTENSILIMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
1Z5YC3ME5N
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TECLISTAMAB
1
Antibody
Investigational
Unknown
Unknown
Hematologic Diseases; Multiple Myeloma; Neoplasms
T cell surface glycoprotein CD3 binding agent
TECLISTAMAB
×
Maximum Phase:
1
First Approval:
None
UNII:
54534MX6Z9
Molecule Type:
Antibody
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
MIK-665
1
Unknown
Investigational
Unknown
Unknown
Leukemia, Myeloid, Acute; Myelodysplastic Syndromes
Unknown
MIK-665
×
Maximum Phase:
1
First Approval:
None
UNII:
801XYWHNOS
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-573
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
TAK-573
×
Maximum Phase:
1
First Approval:
None
UNII:
TN8CEX4UT2
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RG6029
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Sodium channel protein type IX alpha subunit blocker
RG6029
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
TAK-137
1
Unknown
Investigational
Unknown
Unknown
Attention Deficit Disorder with Hyperactivity
Unknown
TAK-137
×
Maximum Phase:
1
First Approval:
None
UNII:
XE1054JW00
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RESOLVIN E1
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RESOLVIN E1
×
Maximum Phase:
1
First Approval:
None
UNII:
GND3JH08JA
Molecule Type:
Small molecule
Molecular Formula:
C20H30O5
Molecular Weight:
350.46
AlogP:
2.91
PSA:
97.99
HBD:
4.0
HBA:
#RotB:
13.0
Source:
SB-85635
1
Small molecule
Investigational
Unknown
Unknown
Unknown
MAP kinase p38 alpha inhibitor
SB-85635
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
OBI-888
1
Unknown
Investigational
Unknown
Unknown
Neoplasms
Unknown
OBI-888
×
Maximum Phase:
1
First Approval:
None
UNII:
JI5TBH62QP
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
BISMUTH TRIBROMOPHENATE
1
Unknown
Investigational
Unknown
Unknown
Infections
Unknown
BISMUTH TRIBROMOPHENATE
×
Maximum Phase:
1
First Approval:
None
UNII:
5K96Y7WG8T
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DOTAMTATE PB-212
1
Unknown
Investigational
Unknown
Unknown
Neuroendocrine Tumors
Unknown
DOTAMTATE PB-212
×
Maximum Phase:
1
First Approval:
None
UNII:
E9N7QV53AK
Molecule Type:
Unknown
Molecular Formula:
C65H91N17O16PbS2
Molecular Weight:
1642.67
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
AZD-8165
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
AZD-8165
×
Maximum Phase:
1
First Approval:
None
UNII:
7WO8I5IY24
Molecule Type:
Small molecule
Molecular Formula:
C23H21ClFN7O4
Molecular Weight:
513.92
AlogP:
2.35
PSA:
131.67
HBD:
1.0
HBA:
#RotB:
8.0
Source:
MUBRITINIB
1
Small molecule
Investigational
Unknown
Unknown
Breast Neoplasms; Kidney Neoplasms; Lung Neoplasms; Ovarian Neoplasms; Pancreatic Neoplasms
Receptor protein-tyrosine kinase erbB-2 inhibitor
MUBRITINIB
×
Maximum Phase:
1
First Approval:
None
UNII:
V734AZP9BR
Molecule Type:
Small molecule
Molecular Formula:
C25H23F3N4O2
Molecular Weight:
468.48
AlogP:
6.06
PSA:
65.97
HBD:
0.0
HBA:
#RotB:
10.0
Source:
PELCITOCLAX
1
Small molecule
Investigational
Unknown
Unknown
Lymphoma, Non-Hodgkin; Neuroendocrine Tumors; Primary Myelofibrosis; Small Cell Lung Carcinoma
Unknown
PELCITOCLAX
×
Maximum Phase:
1
First Approval:
None
UNII:
317UBD60ML
Molecule Type:
Small molecule
Molecular Formula:
C57H66ClF4N6O11PS4
Molecular Weight:
1281.87
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ABC-008
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
ABC-008
×
Maximum Phase:
1
First Approval:
None
UNII:
QT44II3WZP
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PROFILNINE SD
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
PROFILNINE SD
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
RXDX-105
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Unknown
RXDX-105
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
CE-245677
1
Small molecule
Investigational
Unknown
Unknown
Unknown
Tyrosine-protein kinase TIE-2 inhibitor
CE-245677
×
Maximum Phase:
1
First Approval:
None
UNII:
GMH17J9LHL
Molecule Type:
Small molecule
Molecular Formula:
C24H22Cl2N6O3
Molecular Weight:
513.39
AlogP:
5.78
PSA:
124.16
HBD:
3.0
HBA:
#RotB:
6.0
Source:
BMS-830216
1
Small molecule
Investigational
Unknown
Unknown
Obesity
Unknown
BMS-830216
×
Maximum Phase:
1
First Approval:
None
UNII:
ISL723GVQ8
Molecule Type:
Small molecule
Molecular Formula:
C24H22ClN2O7PS
Molecular Weight:
548.94
AlogP:
5.04
PSA:
120.11
HBD:
2.0
HBA:
#RotB:
9.0
Source:
AVL-3288
1
Small molecule
Investigational
Unknown
Unknown
Psychotic Disorders; Schizophrenia
Neuronal acetylcholine receptor protein alpha-7 subunit positive allosteric modulator
AVL-3288
×
Maximum Phase:
1
First Approval:
None
UNII:
VA80VAX4WF
Molecule Type:
Small molecule
Molecular Formula:
C19H15Cl2N3O2
Molecular Weight:
388.25
AlogP:
5.38
PSA:
67.16
HBD:
2.0
HBA:
#RotB:
5.0
Source:
NONOXYNOL
1
Unknown
Investigational
Unknown
Unknown
Unknown
Unknown
NONOXYNOL
×
Maximum Phase:
1
First Approval:
None
UNII:
None
Molecule Type:
Unknown
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PA401
1
Protein
Investigational
Unknown
Unknown
Unknown
Unknown
PA401
×
Maximum Phase:
1
First Approval:
None
UNII:
Molecule Type:
Protein
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
1
2
…
103
104
105
106
107
108
109
…
304
305
Next »
Download Option
Close
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA